Caricamento...
Prognostic Factors for Post-Relapse Survival after ex-vivo CD34(+)-Selected (T cell-depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma
BACKGROUND: Allogeneic hematopoietic cell transplantation (alloHCT) for multiple myeloma (MM), with its underlying graft-versus-tumor capacity, is a potentially curative approach for high-risk patients. Relapse is the main cause of treatment failure, but predictors for post-relapse survival are not...
Salvato in:
| Pubblicato in: | Biol Blood Marrow Transplant |
|---|---|
| Autori principali: | , , , , , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7609585/ https://ncbi.nlm.nih.gov/pubmed/32712326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.07.016 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|